Ariyan Stephan, Ariyan Charlotte, Farber Leonard R, Fischer David S, Flynn Stuart D, Truini Carolyn
Melanoma Unit of the Yale Cancer Center, Department of Surgery, Yale University School of Medicine, New Haven, CT 06510, USA.
J Am Coll Surg. 2004 Jun;198(6):924-32. doi: 10.1016/j.jamcollsurg.2004.01.034.
The purpose of this study of sentinel lymph node biopsies (SLN) was threefold: to compare the reliability of lymphazurin blue dye to radioactive technetium 99m sulfur colloid (TC); to evaluate the reliability of frozen section examinations of sentinel lymph nodes; and to determine how much SLN dissections prolonged operative time.
We evaluated the records of 263 consecutive patients with intermediate and high-risk melanomas (1.0 mm or thicker, or Clark Level IV or greater), who were treated by a single surgeon at the Yale Melanoma Unit between October 1, 1997, and September 30, 2001, and followed for more than 18 months.
A total of 655 SLN were identified and removed from these 263 consecutive patients. Radioactive colloid was found to be more reliable (100%) in identifying the SLN than lymphazurin blue dye (51%) in the nodes of the patients. Twenty-eight patients (11%) had positive sentinel lymph nodes, and 2 patients (7%) had false-negative frozen sections. Three patients (11%) had false-negative frozen sections; tumor was found subsequently on permanent sections only after special immunohistochemical stains were used. The location or removal of SLN did not prolong the operative procedure unreasonably, requiring an average of 7 to 20 minutes for removal of SLN, and 33 minutes for frozen section reports, during which time the primary tumor resection and wound coverage were performed.
SLN were found in all 263 patients. All SLN were identified reliably with radioactive colloid. Because blue dye was found in only half of the radioactive nodes, it is not appropriate to use this as the only marker for locating the SLN. This large series of patients attests to the reliability of frozen sections in identifying SLN harboring metastases, with 82% of the patients with nodal metastases identified in this fashion.
本项前哨淋巴结活检(SLN)研究的目的有三个:比较亚甲蓝染料与放射性锝99m硫胶体(TC)的可靠性;评估前哨淋巴结冰冻切片检查的可靠性;确定前哨淋巴结清扫术延长手术时间的程度。
我们评估了1997年10月1日至2001年9月30日期间在耶鲁黑色素瘤中心由同一位外科医生治疗的263例连续的中高危黑色素瘤患者(肿瘤厚度1.0毫米或更厚,或克拉克分级为IV级或更高)的记录,并对他们进行了超过18个月的随访。
在这263例连续患者中总共识别并切除了655个前哨淋巴结。在患者的淋巴结中,发现放射性胶体在识别前哨淋巴结方面比亚甲蓝染料更可靠(100%对51%)。28例患者(11%)前哨淋巴结阳性,2例患者(7%)冰冻切片为假阴性。3例患者(11%)冰冻切片为假阴性;仅在使用特殊免疫组化染色后,在永久切片上才发现肿瘤。前哨淋巴结的位置或切除并未不合理地延长手术过程,切除前哨淋巴结平均需要7至20分钟,冰冻切片报告需要33分钟,在此期间进行了原发肿瘤切除和伤口覆盖。
在所有263例患者中均发现了前哨淋巴结。所有前哨淋巴结均通过放射性胶体可靠识别。由于仅在一半的放射性淋巴结中发现了蓝色染料,因此将其用作定位前哨淋巴结的唯一标记是不合适的。这一大系列患者证明了冰冻切片在识别有转移的前哨淋巴结方面的可靠性,82%的有淋巴结转移的患者通过这种方式得以识别。